FDA tentatively approves Merck biosimilar pending patent suit settlement

21-07-2017

FDA tentatively approves Merck biosimilar pending patent suit settlement

Michail_Petrov-96 / iStockphoto.com

The US Food and Drug Administration (FDA) has tentatively approved a Merck biosimilar, pending resolution of a patent dispute.


Food and Drug Administration, FDA, Merck & Co, Sanofi, biosimilar, diabetes, patent, patent infringement

LSIPR